Geisinger at AMP 2026
Nov 10–14, 2026 Seattle, WA ~2k attendees Website
Geisinger brings 1 presentation to AMP 2026 in Seattle. Its session covers molecular diagnostics for pancreatic lesions, and how testing sharpens care for patients whose disease is hard to see.
| Organization | AMP 2026 Attendance |
|---|---|
Geisinger Danville, PA | |
Health system in central Pennsylvania that runs the MyCode population genomic screening programme alongside its hospitals and clinics. | Workshop Thu, Nov 12 4:25pm–4:55pm It's Hard to Treat What You Can't See: Leveraging Molecular Diagnostics to Improve Care of Patients with Pancreatic Lesions Pancreatic lesions are hard to call on imaging and cytology alone; molecular testing can sharpen diagnosis and risk stratification. |
Instantly find 20 buyers from Geisinger
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction